Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $227,066 | 81 | 75.8% |
| Travel and Lodging | $39,170 | 55 | 13.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $26,669 | 22 | 8.9% |
| Food and Beverage | $4,787 | 78 | 1.6% |
| Honoraria | $1,600 | 1 | 0.5% |
| Education | $151.28 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $114,055 | 118 | $0 (2024) |
| AstraZeneca UK Limited | $67,127 | 32 | $0 (2021) |
| GlaxoSmithKline, LLC. | $60,557 | 50 | $0 (2024) |
| AstraZeneca AB | $22,463 | 11 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $14,096 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $8,319 | 4 | $0 (2020) |
| Amgen Inc. | $7,040 | 7 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $4,001 | 3 | $0 (2024) |
| ALK-Abello, Inc | $1,651 | 2 | $0 (2021) |
| BOSTON SCIENTIFIC CORPORATION | $85.16 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,382 | 28 | GlaxoSmithKline, LLC. ($8,262) |
| 2023 | $40,853 | 44 | AstraZeneca Pharmaceuticals LP ($23,412) |
| 2022 | $21,136 | 13 | AstraZeneca Pharmaceuticals LP ($12,870) |
| 2021 | $66,956 | 32 | GlaxoSmithKline, LLC. ($25,054) |
| 2020 | $42,491 | 25 | GlaxoSmithKline, LLC. ($12,650) |
| 2019 | $42,343 | 37 | AstraZeneca Pharmaceuticals LP ($22,884) |
| 2018 | $46,206 | 46 | AstraZeneca UK Limited ($29,795) |
| 2017 | $22,077 | 18 | AstraZeneca Pharmaceuticals LP ($14,999) |
All Payment Transactions
243 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | Cash or cash equivalent | $37.50 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/17/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $60.61 | General |
| 08/17/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $54.66 | General |
| 08/17/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $49.99 | General |
| 08/17/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $44.41 | General |
| 08/16/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $270.07 | General |
| 08/16/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $110.28 | General |
| 08/16/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $15.03 | General |
| 07/29/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $401.46 | General |
| 07/29/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $169.25 | General |
| 07/29/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $31.02 | General |
| 07/29/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $31.02 | General |
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $5,881.25 | General |
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $197.22 | General |
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $190.28 | General |
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $130.68 | General |
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $61.79 | General |
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $8.35 | General |
| 03/15/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,275.00 | General |
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $1,455.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $121.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/23/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $63.76 | General |
| 02/23/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $39.57 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 176 | 195 | $46,301 | $8,681 |
| 2022 | 4 | 175 | 200 | $42,780 | $8,500 |
| 2021 | 2 | 109 | 136 | $30,426 | $7,228 |
| 2020 | 6 | 138 | 152 | $27,117 | $5,143 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 83 | $18,119 | $3,636 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 47 | $14,786 | $2,894 | 19.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $9,886 | $1,891 | 19.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 38 | 45 | $3,510 | $259.14 | 7.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 110 | $22,440 | $4,484 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 48 | $14,112 | $3,161 | 22.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $3,888 | $686.57 | 17.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 26 | 30 | $2,340 | $168.76 | 7.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 74 | 89 | $17,266 | $3,642 | 21.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 47 | $13,160 | $3,587 | 27.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 57 | $10,545 | $1,907 | 18.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 27 | $7,182 | $1,461 | 20.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 19 | 19 | $3,059 | $670.33 | 21.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $3,516 | $638.56 | 18.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 20 | 22 | $1,645 | $394.40 | 24.0% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 14 | 15 | $1,170 | $71.72 | 6.1% |
About Sameer Mathur, MD PHD
Sameer Mathur, MD PHD is a Pediatric Allergy/Immunology healthcare provider based in Madison, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063488138.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sameer Mathur, MD PHD has received a total of $299,444 in payments from pharmaceutical and medical device companies, with $17,382 received in 2024. These payments were reported across 243 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($227,066).
As a Medicare-enrolled provider, Mathur has provided services to 598 Medicare beneficiaries, totaling 683 services with total Medicare billing of $29,552. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Pediatric Allergy/Immunology
- Location Madison, WI
- Active Since 02/27/2006
- Last Updated 09/11/2025
- Taxonomy Code 2080P0201X
- Entity Type Individual
- NPI Number 1063488138
Products in Payments
- FASENRA (Drug) $53,820
- NUCALA (Biological) $51,666
- FASENRA (Biological) $39,991
- AIRSUPRA (Drug) $11,243
- SYMBICORT (Drug) $6,904
- STIOLTO RESPIMAT (Drug) $6,150
- DUPIXENT (Biological) $4,001
- SPIRIVA RESPIMAT (Drug) $1,979
- TEZSPIRE (Biological) $1,074
- SPIRIVA (Drug) $190.36
- GENERAL PAIN MANAGEMENT (Device) $85.16
- CINRYZE (Drug) $37.65
- ALVESCO (Drug) $10.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Allergy/Immunology Doctors in Madison
James Gern, Md, MD
Pediatric Allergy/Immunology — Payments: $269,003
Dr. Daniel Jackson, M.d, M.D
Pediatric Allergy/Immunology — Payments: $187,340
Mark Moss, Md, MD
Pediatric Allergy/Immunology — Payments: $93,464
Robert Lemanske, Md, MD
Pediatric Allergy/Immunology — Payments: $18,402
Anne Marie Singh, M.d, M.D
Pediatric Allergy/Immunology — Payments: $12,720
Sima Ramratnam, M.d, M.D
Pediatric Allergy/Immunology — Payments: $4,714